Brief Article
Copyright ©2012 Baishideng.
World J Hepatol. Sep 27, 2012; 4(9): 262-267
Published online Sep 27, 2012. doi: 10.4254/wjh.v4.i9.262
Table 1 Clinicopathological data of patients with autoimmune hepatitiswith and without centrilobular necrosis n (%)
Abbreviations (normal values)With CN (n = 13)Without CN (n = 28)P value
Mean age (range) (yr)51.1 (23-80)52.7 (21-77)NS
Sex (M/F)2/111/27NS
ALT (IU/L)907 (228-3250)667 (224-1761)NS
ALP (IU/L)498 (223-999)450 (76-883)NS
IgG (mg/dL)2307 (1150-3913)3126 (1294-5449)< 0.05
ANA neg.4 (30.7)1 (3.5)< 0.05
Other autoimmune disease4 (30.7)7 (25.0)NS
Steroid therapy11 (84.6)24 (85.7)NS
Azathioprine therapy2 (15.4)7 (25.0)NS
AIH score original12 (6-20)14 (6-18)NS
(Median) simplified6 (3-8)7 (5-8)< 0.05
Interface hepatitis10 (76.9)26 (92.8)NS
Portal inflammation13 (100)24 (85.7)NS
Plasma cell infiltration7 (53.8)7 (25.0)NS
Rosette formation3 (23.1)3 (12.0)NS
Fibrosis
Stage F0-211 (84.6)10 (35.7)< 0.05
Stage F3-42 (15.4)18 (64.3)
Table 2 Clinical and serological features of 13 autoimmune hepatitis patients with centrilobular necrosis
CaseAge (yr)/sexALT (IU/L)ALP (IU/L)IgG (mg/dL)ANA (titer)ASMA (titer)AIH score
HLA
Histology
(O)(S)DR4(I)(L)(R)(E)(F)
156/F8313573330512040208DR4++++3
268/F12304793215640Neg117-+++-3
345/F32504231800160Neg146DR4++--2
449/M713528230064040157DR4+++-1
523/F7895963913160640177DR4++--1
642/M14999721150NegNeg93DR4-+--1
757/F4712232266Neg2063DR4++--1
880/F499410141040Neg114-++--1
952/F4164581280Neg160115--+--1
1044/F10673771370NegNeg63DR4-++-1
1144/F41827335032560Neg147-++--2
1235/F383335308616080177ND++--1
1369/F2289991286160Neg135-++--2